1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Results of Spearman rank correlation test between rCBV and ADC ratios versus cell and microvessel density
Density All Samples (n = 18, N = 81) Peritumoral Tissue (n = 4, N = 9) Infiltrated Tissue (n = 17, N = 39) Bulk Tumor (n = 13, N = 33) r (P) r (P) r (P) r(P) ADC-cell 0.11 (.34) 0.02 (.97) −0.02 (.90) −0.20 (.26) ADC-microvessel −0.20 (.08) −0.62 (.08) −0.06 (.72) −0.36 (.04)* rCBV-cell 0.37 (.0006)* −0.07 (.86) 0.09 (.59) 0.57 (.0005)* rCBV-microvessel 0.26 (.02)* 0.03 (.93) −0.18 (.28) 0.46 (.008)*
Note:—nindicates number of patients; N, number of biopsy samples.
* Statistically significant with P < .05.